Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05174650
Title Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
HELIOS KLinikum Bad Saarow RECRUITING Bad Saarow Germany Details
MVZ am Oskar-Helene Heim Berlin RECRUITING Berlin Germany Details
Universitätsmedizin Berlin Charité NOT_YET_RECRUITING Berlin Germany Details
Vivantes Klinikum Berlin Friedrichshain RECRUITING Berlin Germany Details
Johanniter Krankenhaus Bonn RECRUITING Bonn Germany Details
Uniklinikum Köln RECRUITING Cologne Germany Details
Donauisar Klinikum Deggendorf RECRUITING Deggendorf Germany Details
Klinikum Esslingen RECRUITING Esslingen Germany Details
Krankenhaus Nordwest gGmbH RECRUITING Frankfurt Germany Details
Medizinische Hochschule Hannover RECRUITING Hannover Germany Details
Universitätsklinikum Jena RECRUITING Jena Germany Details
Alexianer Krefeld GmbH RECRUITING Krefeld Germany Details
Universitätsklinikum Leipzig RECRUITING Leipzig Germany Details
Universitätsmedizin Mainz RECRUITING Mainz Germany Details
Universitätsmedizin Mannheim RECRUITING Mannheim Germany Details
LMU München Großhadern RECRUITING Munich Germany Details
Klinikum rechts der Isar, Technische Universität München RECRUITING München Germany Details
Universitätsklinikum Tübingen RECRUITING Tübingen Germany Details
Marienhospital Wesel RECRUITING Wesel Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field